National Institute of Allergy and Infectious Diseases, National Institutes of Health - Wednesday, Dec. 10, 2003
Jennifer Wenger (301) 402-1663, jwenger@niaid.nih.gov
How anti-HIV drugs are combined and the order in which they are given are important factors to consider when designing treatment strategies for patients new to antiretroviral therapy, says a new study funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health.
National Institute of Allergy and Infectious Diseases, National Institutes of Health - December 1, 2003
Anthony S. Fauci, M.D., NIAID Director
The annual observance of World AIDS Day reminds us of the immense challenges facing the global community as we work to slow the trajectory of—and ultimately terminate—the global HIV/AIDS pandemic. World AIDS Day also provides an opportunity to express our appreciation to the many scientists, health care workers, policy
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Monday, Dec. 1, 2003
Anthony S. Fauci, M.D.
The annual observance of World AIDS Day reminds us of the immense challenges facing the global community as we work to slow the trajectory of -- and ultimately terminate -- the global HIV/AIDS pandemic. World AIDS Day also provides an opportunity to express our appreciation to the many scientists, health care workers,
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Wednesday, Aug. 27, 2003
John Bowersox - jbowersox@niaid.nih.gov (301) 402-1663
Prescribed interruptions in antiretroviral therapy--so-called drug holidays --may hasten disease progression in a subset of HIV-infected individuals, namely those whose treatment has been rendered significantly less effective by the development of resistance to multiple anti-HIV drugs (MDR-HIV). This was the finding in
National Institute of Allergy and Infectious Diseases, National Institutes of Health - February 7, 2003
Anthony S. Fauci, M.D., NIAID Director
Today, the National Institute of Allergy and Infectious Diseases (NIAID) is proud to stand with hundreds of national, regional and local HIV/AIDS groups in observing the third annual National Black HIV/AIDS Awareness Day. This critical effort to mobilize community-based efforts to educate African Americans about the de
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Monday, Jan 27, 2003
Walter Mitton, (301) 402-1663, mitton@niaid.nih.gov
Research Reveals How Strep Bacterium Evades Immune System Like a well-trained soldier with honed survival skills, the common bacterium, Group A Streptococcus (GAS), sometimes can endure battle with our inborn (innate) immune system and cause widespread disease. By investigating the ability of combat-ready white blood c
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Friday, January 24, 2003
James Hadley, (301) 402-1663, jhadley@nih.gov
HHS Secretary Names Five to NIAID Advisory Council HHS Secretary Tommy G. Thompson today announced five appointments to the National Advisory Allergy and Infectious Diseases Council, the principal advisory body of the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Friday, January 10, 2003
NIAID Press Office, (301) 402-1663
HHS Announces Research Plan To Fight Autoimmune Diseases HHS Secretary Tommy G. Thompson today announced the release of a comprehensive research plan from HHS National Institutes of Health (NIH) to fight autoimmune diseases, a collection of disorders including multiple sclerosis and rheumatoid arthritis that affect an
National Institute of Allergy and Infectious Diseases, National Institutes of Health - Wednesday, January 8, 2003
Anne Oplinger, (301) 402-1663, aoplinger@niaid.nih.gov
Powerful Technologies Probe Innate Immunity A comprehensive and detailed picture of innate immunity-the human body s first line of defense against disease-is the goal of scientists funded by a recently awarded five-year, $24-million grant from the National Institute of Allergy and Infectious Diseases (NIAID). Researche
This information is designed to support, not replace, the relationship that exists between you and your doctor.